← The Wire
ASMBNasdaq
ASSEMBLY BIOSCIENCES, INC.
Pharmaceutical Preparations · DE · CIK 1426800
Developing innovative therapeutics targeting serious viral diseases like herpes, hepatitis delta, and hepatitis B
red 8-K · 90d
$455M
Market cap
$26.96
Last close
+0.8%
1D
+7.2%
5D
236K
Volume
Price · last 39 sessions-3.1%
May 4L $22.26 · H $31.72Jun 29
360
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
SC 13GSC 13GNov 14, 2024SC 13GSC 13GOct 12, 2021SC 13GCONSONANCE CAPITAL MANAGEMENT LPFeb 17, 2021SC 13GSC 13GFeb 16, 2021SC 13GCONSONANCE CAPITAL MANAGEMENT LPFeb 16, 2021SC 13GCONSONANCE CAPITAL MANAGEMENT LPFeb 16, 2021SC 13GSCHEDULE 13GFeb 10, 2021SC 13GSC 13GJan 4, 2021SC 13GCONSONANCE CAPITAL MANAGEMENT LPFeb 14, 2020SC 13GSC 13GDec 23, 2019SC 13GSCHEDULE 13G HOLDINGS REPORTOct 7, 2019SC 13GSC 13GApr 25, 2019SC 13GSC 13GFeb 14, 2019SC 13GSEC SCHEDULE 13GFeb 12, 2019SC 13GSC 13GFeb 14, 2018SC 13GSC 13GFeb 12, 2018SC 13GSC 13GFeb 1, 2018SC 13GSC 13GFeb 13, 2017SC 13GSCHEDULE 13GFeb 12, 2016SC 13GSC 13GFeb 13, 2015SC 13G13G INITIAL ANNUAL FILING - ASMBFeb 9, 2015SC 13GSC 13GJan 2, 2015SC 13GSCHEDULE 13GOct 8, 2014SC 13GSC 13GFeb 14, 2014SC 13GSCHEDULE 13GFeb 11, 2013SC 13GSC 13GFeb 5, 2013SC 13GSC 13GFeb 4, 2013SC 13GSC 13GFeb 1, 2013SC 13GSABBY 13G VTUS 012413Jan 24, 2013SC 13GSC 13GJul 3, 2012SC 13GFORM SC 13GApr 2, 2012SC 13GSC 13GFeb 14, 2012SC 13GSC 13GFeb 14, 2012SC 13GVENTRUS BIOSCIENCES INC 13G ANNUAL FILINGFeb 14, 2012SC 13GSC 13GFeb 14, 2012SC 13GSC 13GAug 12, 2011SC 13GDECEMBER 27, 2010Dec 27, 2010
Insider Activity
In the 90 days to Mar 30, 2026: 2 sold $14K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Bjorkquist Jeanette MPFO and PAO | Sell | 312 | $26.65 | $8K |
| Mar 30, 2026 | White Nicole SChief Manufacturing Officer | Sell | 188 | $26.65 | $5K |
| Mar 30, 2026 | Bjorkquist Jeanette MPFO and PAO | Sell | 16 | $27.49 | $440 |
| Mar 30, 2026 | White Nicole SChief Manufacturing Officer | Sell | 9 | $27.49 | $247 |
| Aug 8, 2025 | Gilead Sciences, Inc.TenPercentOwner | Buy | 2,295,920 | — | — |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance